GV logo

GV

0 followers

About GV

GV is a venture capital firm that supports innovative founders moving the world forward, with a focus on consumer, enterprise, life sciences, and frontier tech sectors.

Recent News

Isomorphic Labs Raises $2.1 B to Expand AI-Driven Drug Discovery Platform

FinTech Funding Continues Strong Run with over $800m Raised This Week

Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug

Flick Raises $6M for Filmmaker-First AI Video Tools

Syremis Therapeutics Raises $165M in Series A Financing

Pinterest Alternative Cosmos Is Looking to Redefine Visual Inspiration for Creatives

Sierra Raises $950M as the Race to Own Enterprise AI Gets Serious

Alphabet's Isomorphic Labs Raises $2.1 Billion to Scale AI Drug Discovery Toward Clinical Trials

Omni Scoops Up $120M at $1.5B Valuation

GV-Backed Biotech Startup OMass Faces IP Lawsuit

Makary Resigns, BMS Bets $15B on China R&D, and Regenxbio Wins Phase 3 in Duchenne – This Week in Biotech #100

Lawhive Closes $60M Series B for Consumer Legal AI

Investors Share What to Remember While Raising a Series A

Menlo Partner Deedy Das Says Wealth Won’t Cure Silicon Valley Founder Blues

Flourish Raises $500 Million Series B, Valued at $2.5 B to Build Brain‑Inspired AI

Nectar Social Secures $30M Series A to Scale AI‑Powered Marketing OS

Signos Grows Foothold in Weight Loss Wave Fueled by GLP-1s with Its AI Health Data Tracking

Sierra Secures $950 Million Funding, Valued at $15 Billion to Scale AI‑Driven CX Platform

Recursive Superintelligence Secures $650M Seed Round at $4.65B Valuation

The Week’s 10 Biggest Funding Rounds: XAI Leads As 2026 Is Off To A Brisk Start

OpenEvidence Brings Hands-Free Medical AI to 860,000 Clinicians

Synthesia Announces Major Hiring Push, Opens Three New Offices

Isomorphic Labs Pulls $2.1B Series B Led By Thrive With MGX, Temasek, And UK Sovereign AI Fund: What The Capital Stack, IsoDDE Engine, And Novartis/Lilly/J&J Partnerships Mean For Drug Discovery

Quiet Week for FinTechs with Just over $450m Raised in Total Deals

One-Time Hot Insurance Tech Ethos Poised to Be First Tech IPO of the Year

Synthesia Hits $4B Valuation, Lets Employees Cash Out

J&J Bets on Isomorphic for AI-Powered Drug Hunt

The Private Assets Held in Public Companies

AI-Powered Fragrance Company Osmo Raises $70 Million in Series B Funding

Delve Detect Enables Neurologists to Treat CNS Infections When Conventional Testing Fails

Syneron Raises $150m for Macrocyclics, and Other Financings

GV Backs MokN’s $15m Bid to Flip the Script on Phishing

SmallSat Europe Speaker Focus: Simon Van Den Dries, EnduroSat

Gate Bioscience Raises $65M in Series B Financing

Paradigm Health Raises $78M in Series B Funding

Omni Secures $120 Million Series C at $1.5 B Valuation, Led by ICONIQ

Uber-Backed Electric Scooter Rental Firm Lime Files for IPO

What Is Series Funding A, B, and C?

Wealth.com Nabs $65M Series B Round

Isomorphic Labs Raises $2.1 B Series B to Scale AI Drug‑Design Engine

Isomorphic Labs Secures $2.1 B Series B to Accelerate AI Drug Discovery

MokN Raises €12.9 Million to Combat Credential Theft as GV Makes Its First Investment in a French Startup

Prudentia Sciences Secures $20M Series A Financing

Lawhive Raises $60M in Series B Funding

Mandiant’s Founder Just Raised $190M for His Autonomous AI Agent Security Startup

AI Startup Sierra Secures $950 Million Funding, Nears $1 Billion Valuation

SolveAI Raises $50M to Help Employees Build Their Own Enterprise Software

EXCL: HMRC Signs £150k Deal for AI-Generated Comms and Training Videos

Isomorphic Raises $2.1bn for AI Drug Hunt

OpenEvidence, An AI-Powered ‘Brain Extender’ For Doctors, Doubles Valuation To $12B With $250M Series D

Recent Deals

Resistant AI Raises $25M Series B to Expand Fraud Prevention AI Internationally

October 13, 2025

Pelage Pharmaceuticals Closes $120M Series B Led by ARCH Venture Partners and GV

October 15, 2025

Odyssey Raises Series A Led by EQT Ventures

December 1, 2024

Synthesia Raises $200M in Latest Funding Round, Valuation Jumps to $4B

January 26, 2026

Gate Bioscience Secures $65M Series B Round Led by Forbion and Eli Lilly

November 13, 2025

Paradigm Health Secures $78M Series B Led by ARCH Venture Partners

December 4, 2025

EpiBiologics Raises $107M in Series B to Advance Protein-Degrading Cancer Drug

January 8, 2026

GV Leads $27M Series A Funding for Translucent, AI Healthcare Finance Platform

March 11, 2026

Syremes Therapeutics Secures $165M Series A to Advance Mental‑Health Drug Pipeline

December 19, 2025

Prudentia Sciences Raises $20M Series A Led by McKesson Ventures

January 7, 2026

Signos Raises $20M for Glucose Monitoring System for Weight Management

May 27, 2026

Navier Secures $5.6M Seed Funding to Launch Autonomous Engineering Teams

December 15, 2025

Pelage Pharmaceuticals Raises $120M in Series B Co-Led by ARCH and GV

October 15, 2025

Midi Health Secures $100M Series D Funding Led by Goodwater Capital

February 3, 2026

OpenEvidence Raises $200M at $6B Valuation to Scale Medical AI

October 20, 2025

Wealth.com Raises $65M Series B to Expand AI-Powered Wealth Management Platform

April 17, 2026

Counsel Health Raises $25M Series A Led by A16z and GV

October 17, 2025

Harvey Raises $300M Series E at $5B Valuation

October 17, 2025

Counsel Health Raises $25M Series A Led by A16z and GV

October 17, 2025